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Hand exercise for women with rheumatoid
arthritis and decreased hand function: an
exploratory randomized controlled trial
Karen Ellegaard1*, Cecilie von Bülow1,2, Alice Røpke3, Cecilie Bartholdy1,4, Inge Skovby Hansen4,
Signe Rifbjerg-Madsen1, Marius Henriksen1,4 and Eva Ejlersen Wæhrens1,2
Abstract
Background: People with hand-related rheumatoid arthritis (RA) experience problems performing activities of daily
living (ADL). Compensatory strategies to improve ADL ability have shown effective. Similarly, hand exercise has shown
effect on pain, grip strength, and self-reported ability. A combination has shown positive effects based on self-report,
but self-report and observation provide distinct information about ADL. The purpose of this study was to examine
whether hand exercise as add on to compensatory intervention (CIP) will improve observed ADL ability in RA.
Methods: Women (n = 55) with hand-related RA were randomized to CIPEXERCISE (intervention) or CIP only (control). CIP
is focused on joint protection, assistive devices, and alternative ways of performing AD. The hand-exercise program
addressed range of motion and muscle strength.
Primary outcome was change in observed ADL motor ability measured by the Assessment of Motor and Process Skills
(AMPS). Baseline measures were repeated after 8 weeks.
Results: Improvements in ADL motor ability in CIPEXERCISE (mean change = 0.24 logits; 95% CI = 0.09 to 0.39) and
CIPCONTROL (mean change =0.20 logits; 95% CI = 0.05 to 0.35) were statistically significant, with no differences between
groups (mean difference = 0.04 logits; 95% CI = − 0.16 to 0.25). Thirteen (46.4%) participants in the CIPEXERCISE and 12
(44.4%) in the CIPCONTROL obtained clinically relevant improvements (≥ 0.30 logits) in ADL motor ability; this group
difference was not significant (z = 0.15; p = 0.88).
Conclusion: Adding hand exercise to a compensatory intervention did not yield additional benefits in women with
hand-related RA.
The study was approved by the ethics committee 14th of April 2014 (H-3-2014-025) and registered at ClinicalTrials.gov
16th of May 2014 (NCT02140866).
Keywords: Rheumatoid arthritis, Hand function, ADL performance, Exercise program, Observational based assessment
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune dis-
ease characterized by inflammation of synovium [1]. In
90% of RA patients, joints of the hand are affected result-
ing in problems performing activities of daily living (ADL)
[2, 3]. A study by Thyberg et al. indicates that low grip
strength may play a role in decreased ADL ability [4].
Hand-exercise programs may have positive effects on
hand function in RA [5–9]. A randomized trial including
patients with RA-related hand problems showed positive
effects on hand function after hand exercise added to a
1.5-h instruction in joint protection, without negative ef-
fect on disease activity [8–10].
Compensatory programs based on individualized joint
protection and education in coping strategies to improve
performance of ADL tasks have shown to be effective
[11–13]. Hammond et al. found that patients with RA,
diagnosed within < 5 years, attending an educational-
behavioral joint protection program, maintained ADL
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ability after 4 years [11, 12]. Masiero et al. showed that
patients with RA presented with less pain and disability
8 months after an educational-behavioral joint protec-
tion program [13].
Clinical guidelines recommend that patients with RA
receive hand-exercise programs focusing on increasing
muscle strength and movements and programs on com-
pensatory strategies to overcome difficulties in ADL task
performance related to hand impairments [14].
However, existing evidence of the effectiveness of hand
exercise on functional ability is based on self-reported
data, typically questionnaires. While self-report repre-
sents the patient’s perspective, it is documented that
measures of self-reported ADL ability have low to mod-
erate relationship to observation-based ADL ability mea-
sures [3, 15]. Thus, self-reported and observation-based
measures provide distinct but complementary informa-
tion [3, 15]. Observation-based evaluations of ADL abil-
ity are considered to provide more neutral measures
than evaluations based on self-report, as observations
seem less influenced by psychosocial factors and pain
[16]. Furthermore, observation-based evaluations have
shown to be more sensitive to change after intervention
among patients with chronic pain [17].
It remains to be tested whether hand-exercise therapy
as an add on to a compensatory intervention program
(CIP) will improve the observable performance of ADL
tasks requiring hand function in patients with RA.
Moreover, as suppression of disease activity is essential
to avoid progression of joints destruction [18, 19], it is
relevant to explore changes in disease activity after
therapeutic interventions.
It was hypothesized that hand-exercise therapy as an
add on to CIP in patients with RA-related hand impair-
ments would result in larger improvements in observed
ADL ability as compared to CIP alone, without increas-
ing disease activity.
Patients and methods
Participants
Participants were females with RA reporting ADL task
performance problems involving the hands, recruited
from May 2014 to January 2016 through rheumatologists
at outpatient clinics in Copenhagen and announcements
in daily press. Potential participants were given further in-
formation and pre-screened for eligibility via telephone. If
inclined to participate, they were examined by a rheuma-
tologist to determine if they fulfilled inclusion criteria.
Inclusion criteria are as follows: females aged > 18
years; diagnosed with RA (ACR/EULAR 2010 Criteria)
[20]; involvement of minimum of one tender wrist,
MCP, or PIP joint; stable medication 3 months prior to
participation, and self-reported decreased ability to per-
form ADL tasks involving the hands. Exclusion criteria
are as follows: significant osteoarthritis of the hand
(assessed by the rheumatologist); hand surgery within
6 months; other pain condition involving muscles and/
or joints; prednisolone therapy; alternative treatments
during study period; change in medical treatment during
study period; inability to understand Danish; and finally
any other contradictions for participating assessed by
the rheumatologist. Participants were asked not to par-
ticipate in occupational or physical therapy interventions
elsewhere during the study period, aquatic physical ther-
apy was allowed.
Ethics approval and consent to participate
Participants gave written informed consent. The study
was approved by the ethics committee of the Capital Re-
gion of Denmark (H-3-2014-025) and registered at Clini-
calTrials.gov (NCT02140866). The study was conducted
in accordance with standards of the responsible commit-
tee on human experimentation and the Declaration of
Helsinki. If participants experienced increased disease
activity during the study period, US and rheumatologist
examinations were made to determine if modifications
or withdrawal were needed.
Study design and randomization
The investigator-initiated study was designed as an RCT
with parallel groups. Participants entered an 8-week pro-
gram and were randomly assigned to either intervention
group (hand-exercise therapy and CIP, CIPEXERCISE) or con-
trol group (CIP alone, CIPCONTROL) with a 1:1 equal alloca-
tion ratio utilizing a concealment process. Randomization
was made using sealed envelopes and carried out by the pro-
ject secretary. The outcome assessors and data analysts were
kept blinded to the allocation, and participants were
instructed not to convey their group allocation. The persons
performing US examination and evaluation were blinded to
results of clinical examination and group allocation.
Intervention programs
The CIP consisted of an introduction to compensatory
strategies including joint protection (JP), assistive devices,
and alternative methods of performing ADL [21, 22]. The
program was client-centered focusing on improving the
ability to perform those ADL tasks that the single partici-
pant identified as purposeful to her life. It consisted of
four 1-h sessions during an 8-week period. One occupa-
tional therapist (OT) (ISH) with > 10 years of experience
performed all sessions. The first session aimed to identify
the participant’s individual resources and problems in
ADL task performance, goal setting focused on ADL task
performance, and introduction to assistive devices. As
homework, assistive devices were applied at home and the
utility evaluated. In the second session, the OT presented
JP principles and discussed these in relation to the
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participant’s ADL task problems. She supervised the par-
ticipant to integrate JP principles and alternative methods
of doing in ADL tasks. In the third session, the OT
followed up on the use of JP principles and assistive de-
vices at home and together they identified any additional
ADL task, representing a challenge, and performed this
under supervision. Optionally, additional assistive devices
were handed out. As homework, the participant practiced
JP principles and assistive devices in the chosen task.
Fourth session, the OT followed up on homework, evalu-
ated goals, and introduced how to apply for assistive de-
vices and housing accessibility solutions in the home
municipality. This fourth session, if relevant, was done as
a telephone meeting.
The hand-exercise program lasted for 8 weeks as a
strength increase is possible within this time frame and
was designed based on recent research [6, 8, 23–25].
First, the exercise intervention was performed four times
per week with one session supervised by a physical ther-
apist (PT), and the other three were home based. After
14 days. One PT (CB) with 3 years of experience per-
formed the individual exercise sessions. Home-based ex-
ercise sessions were recorded in a diary. During the
period, the exercise intervention was increased to once
daily and the load was increased. The program consisted
of three parts: (1) warm-up/mobility (10 min), (2) muscle
strength training (20 min), and (3) cool-down (5 min).
The warm-up was performed to prepare the joints for
the muscle strength training and to improve flexibility;
the muscle strength training was designed to ensure that
relevant muscle was targeted within a period of 20 min.
Resistance was supplied by exercise bands and Thera-
putty. The amount of resistance was based on the weak-
est hand. The resistance intensity was set according to
the participant’s self-reported experience of load using
the Borg Scale [26]. This load was chosen to minimize
the risk of flare-up symptoms due to overload and to
allow for progression. For cool-down, some of the
warm-up exercises were receded. All participants re-
ceived a detailed illustrated description of the exercise
program (Additional file 2). In case of any flare-up in
symptoms, the participant was set to only conduct the
warm-up and cool-down part. Post exercise soreness
and temporary fatigue was tolerated. Detailed description
of the exercise program is presented in Additional file 3. If
a participant failed to meet at an appointment, a phone
call was made to maintain fidelity.
Outcomes
Primary outcome was observed, ADL motor ability mea-
sured by Assessment of Motor and Process Skills
(AMPS).
Secondary outcomes were observed, ADL process ability
(AMPS), self-reported ADL ability (ADL-Questionnaire,
ADL-Q), self-reported disability (Stanford Health Assess-
ment Questionnaire Disability Index, HAQ-DI), overall
disease activity (DAS28), grip strength, and pain. Explora-
tory outcome was disease activity assessed by US.
AMPS
The AMPS is a standardized observation-based tool
used to measure a person’s observed ADL task perform-
ance [27, 28]. The person being evaluated chooses and
performs at least two standardized ADL tasks of
relevance and appropriate challenge. During AMPS
evaluation, two domains are evaluated, i.e., ADL motor
ability (the amount of effort, fatigue and/or clumsiness)
and ADL process ability (the degree of disorganization,
inappropriate use of time, space, objects and ability to
adapt actions). The 16 ADL motor and 20 ADL process
skills are evaluated in terms of ease, efficiency, safety,
and independence using a four-point ordinal scale. The
available AMPS software [29], based on a many-faceted
Rasch measurement model, makes it possible to convert
ordinal raw scores into overall linear ADL motor ability
measures and overall linear ADL process ability mea-
sures adjusted for task challenge, skill item difficulty,
and rater severity. Measures are expressed in logits (log-
odds probability units) [28]. The overall ADL motor
ability measure indicates how much effort or fatigue the
person demonstrated, and the overall ADL process abil-
ity measure indicates how efficient the person was ob-
served to be during the ADL task performance.
Additionally, both ADL ability measures reflect safety
and independence in ADL task performance. ADL ability
measures above the 2.0 logit cutoff on the ADL motor
scale and above the 1.0 logit cutoff on the ADL process
scale indicate effortless, efficient, safe, and independent
ADL task performance in everyday life. In contrast, ADL
motor ability measures below the 2.0 logits cutoff indi-
cate increased effort or fatigue during task performance.
Moreover, ADL ability measures below the 1.50 ADL
motor cutoff and/or below the 1.00 ADL process cutoff
indicate a need for minimal assistance for community
living. Finally, according to the AMPS manual a differ-
ence of > 0.30 logits on the AMPS ADL motor and/or
ADL process scale defines a clinically relevant change
[28]. Studies support that the AMPS ability measures are
reliable and valid in RA patients [3].
ADL-Q
Self-reported ADL ability was assessed using the ADL-
Q, a standardized instrument with 47 ADL tasks devel-
oped to measure a person’s perceived quality of ADL
performance [3, 30]. The person marks the quality of the
ADL task performance using seven response categories
reflecting efficiency, effort/fatigue, safety, and independ-
ence. Rasch methods are applied [30]. Studies support
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that the ADL-Q can be used to generate valid measures
of self-reported quality of ADL task performance among
RA patients [3].
HAQ-DI
The HAQ-DI is developed to assess disability in RA [21].
The questionnaire consists of 20 questions primarily con-
cerning ADL tasks, a Danish version was used [31].
DAS28
Overall disease activity was assessed using the DAS28
which is based on count of 28 joints for swelling and
tenderness, C-reactive protein level in the blood and the
patient’s self-reported impact of disease on a visual ana-
log scale (VAS Global health). The DAS28 score range
from 0 to 9.4 [32].
Grip strength
The maximal grip strength was measured in kilogram
using a digital hand Dynamometer (North Coast Medical
Inc.). The grip strength was measured three times in
both hands. The maximal force performed in each hand
was used in the analysis.
Pain
Hand pain during activity and in rest was measured in
both hands on a visual analog scale (VAS), where zero
was no pain and 100 was maximal pain.
Ultrasound examination
Synovial hypertrophy and increased synovial perfusion
are indications of disease activity assessed by US [33].
Gray scale US is used to examine synovial hypertrophy
seen as hypo-echoic structure between the tendon/
muscle and the bone [1]. Doppler US added to the gray
scale image register movement of the blood as an indica-
tion of increased synovial perfusion. US has shown to
correlate with measures of disease activity in RA [19, 34,
35]. US examination in RA has shown to display sub
clinical disease activity leading to disease progression on
X-ray [36]. The wrist and MCP 2–5 were examined both
dorsal and palmar. The wrist was scanned in four dorsal
and one volar position and the MCP joints in three dor-
sal and one volar position. Both synovial hypertrophy
and Doppler were evaluated using a validated scoring
system for RA [37]. One score for synovial hypertrophy,
one score for synovial perfusion (Doppler), and one sum
score were calculated.
Sample size
Sample size calculation was based on previous data on
AMPS ADL motor ability in women with RA [3]. For a
two sample pooled t-test of a normal mean difference
with pooled variances (equal variances assumed) and a
two-sided significance level of 5% (p ≤ 0.05), assuming a
common standard deviation (SD) of 0.36 logits, a sample
size of n = 32 participants per group was required to ob-
tain a power of at least 90% to detect a group mean dif-
ference of 0.3 logits. It was decided to include n = 45
participants in each group.
Statistical analysis
Data analyses were carried out according to a pre-
established statistical analysis plan (SAP); all analyses
were done applying SAS (v. 9.4, SAS Institute Inc., Cary,
NC, USA). Descriptive statistics and tests are reported
in accordance to the “Enhancing the QUAlity and
Transparency Of health Research” (EQUATOR) network
[38, 39]. To evaluate the empirical distributions of the
continuous outcomes, visual inspection was applied to
suggest whether the assumption of normality was rea-
sonable. The PROCUNIVARIATE statement was used
for summarizing the data (descriptive statistics).
Intention-to-treat (ITT) analyses were made, i.e., ana-
lyzing participant outcomes according to the group to
which they were allocated, even if participants did not
receive allocated intervention. The ITT principle was
done by replacing missing data with the value obtained
at baseline.
At week 8, the CIPEXERCISE group was compared with
the CIPCONTROL group using general linear model (ana-
lyses of covariance; ANCOVA) for mean changes from
baseline and t tests for comparison of least squares
means between groups. The model included change as
the dependent variable (Δ), with treatment group as a
main effect and the baseline score as an additional
covariate. Results were expressed as the difference between
the group means and 95% CI with the associated p values,
based on the general linear model.
For sensitivity purposes, the analyses were repeated
with further adjustment for disease duration and hand
pain at baseline as there were group imbalances in these
variables at baseline (Additional file 1: Table S1).
The proportion of participants responding to therapy
(≥ 0.30 logits on the AMPS ADL motor scale) was ana-
lyzed using z test to evaluate the difference in the num-
ber of responders between groups.
Results
Fifty-five were randomized to CIPEXERCISE (n = 28) or
CIPCONTROL (n = 27); 22 and 25 participants, respect-
ively, completed the trial (Fig. 1). Reason for drop out in
CIPCONTROL was change in medication. In CIPEXERCISE,
one changed medication, three had flare-up in other dis-
eases, one died of another disease, and one found the
intervention too time consuming. Due to loss of the
AMPS ADL motor ability measure at baseline for one
participant in CIPEXERCISE, the ITT population consisted
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of n = 27 in each group. The ITT population’s mean age
was 63.7 (SD = 13.0) years, and mean disease duration
was 12.6 (SD = 11.1) years. Mean baseline tender and
swollen joint count (28 joints) was 5.0 (SD = 4.8) and 1.4
(SD = 1.7), respectively; the mean hand pain in activity
was 42.7 (SD = 26.1) (right) and 36.2 (SD = 27.6) (left)
mm VAS. Mean baseline AMPS ADL motor ability
measure was 1.4 (SD = 0.5) logits. Mean baseline HAQ
score was 1.1 (SD = 0.6). For other baseline characteris-
tics, see Table 1.
The CIPEXERCISE group attended a mean of 2.4 (SD =
1.2) CIP sessions, whereas the participants in the CIPCON-
TROL attended 2.7 (SD = 1.0) CIP sessions. The average
number of hand-exercise sessions was 20.2 (SD = 10.3).
Exercise diary was received from 24 of the 27 participants.
The hand-exercise program was delivered as intended (see
Additional file 3).
No significant mean differences in changes from base-
line were seen between groups in any of the outcomes
(Table 2). Still, tendencies towards differences between
groups in changes in DAS28 score, CRP, and ESR were
seen. Improvements in primary outcome, observed ADL
motor ability, were seen in both groups, in the CIPEXER-
CISE (ADL motor mean change = 0.24 logits; 95% CI =
0.09 to 0.39) and CIPCONTROL (ADL motor mean
change = 0.20 logits; 95% CI = 0.05 to 0.35), however
with no statistically significant difference between
groups (ADL motor mean difference = 0.04 logits; 95%
CI = − 0.16 to 0.25). A significant increase in grip
strength in the right hand was seen in the CIPEXERCISE
group and ESR increased significantly in the CIPCON-
TROL group (Table 2).
The sensitivity analyses confirmed the primary ana-
lyses and supported further the tendencies towards
group differences in DAS28, HAQ-DI, and ultrasound
total score (Additional file 1: Table S1).
The responder analysis revealed that 13 (46.4%) partic-
ipants in the CIPEXERCISE and 12 (44.4%) in the CIPCON-
TROL obtained clinically relevant improvements (≥ 0.30)
in ADL motor ability, and this difference was not signifi-
cant (z = 0.15; p = 0.88).
Discussion
Based on the results of this study, it was not possible to
confirm the hypothesis that hand-exercise therapy as
add on to a compensatory intervention program in pa-
tients with decreased ADL ability, following RA-related
hand impairments, would result in larger improvements
in observed ADL ability as compared to CIP alone.
While no statistically significant differences in changes
in primary and secondary outcomes were seen between
groups, both groups obtained statistically significant
Fig. 1 CONSORT flow diagram of the study
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improvements in the primary outcome, observed ADL
motor ability. While the mean increases in ADL motor
ability in both groups were not clinically relevant, re-
sponder analysis revealed that almost half of the partici-
pants (46.3%) achieved a clinically relevant (i.e., > 0.3
logits) increase in observed ADL ability. These results,
and the fact that the number of responders in each group
was almost the same, suggest that a large percentage of
the participants benefitted from the CIP intervention.
The CIPEXERCISE group received hand exercise as a re-
storative add on to the CIP intervention. It was assumed
that increasing strength and flexibility of the hands
would translate into improved ADL ability. While this
was not the case, participants in the CIPEXERCISE group
still obtained a significant increase in grip strength,
which was not observed in the CIPCONTROL group. This
suggests that hand exercise may improve strength, but
that such improvements not necessarily translate into
improved ADL ability. This indication of a benefit of the
exercise program is further implied by a minor decrease
in DAS28 score seen in the CIPEXERCISE group as com-
pared to the CIPCONTROL group. However, the change in
Table 1 Baseline characteristics for all randomized participants
CIPEXERCISE (n=27)
Mean (SD)/ Median (IQR)
CIPCONTROL (n=27)
Mean (SD)/ Median (IQR)
Total (54)
Mean (SD)/ Median (IQR)
Age (Years) 64.8 (13.5) 62.6 (12.0) 63.7 (12.8)
Weight (Kg) 69.4 (12.3) 70.0 (11.9) 70.2 (12.5)
Height (Cm) 167.6 (7.4) 166.2 (7.4) 166.9 (7.4)
Start symptoms (Years) 11.3 (3.5:22.5) 14.1 (7.9:18.2) 11.9 (4.7:20.3)
Disease duration (Years) 3.1 (0.4:11.6) 10.3 (7.3:14.6) 7.6 (1.6:13.5)
AMPS ADL motora (Logits) 1.34 (0.4) 1.38 (0.5) 1.36 (0.5)
AMPS ADL processa (Logits) 1.20 (0.2) 1.13 (0.2) 1.27 (0.2)
ADL-Questionnaire (Logits) 0.4 (0.1) 0.5 (0.5) 0.5 (0.3)
HAQ-DIb 1.1 (0.6) 1.1 (0.6) 1.1 (0.6)
Hand strength and pain
Maximal grip strength (Kg)
Right 17.7 (7.7) 18.7 (8.1) 18.2 (7.8)
Left 17.2 (6.3) 17.8 (5.7) 17.5 (6.0)
Hand pain: Activity (mm VAS)
Right 50 (25.0:62.0) 32 (19.5:68.5) 40.5 (21.25:63:75)
Left 50 (11.0:65.5) 26 (10.5:52.0) 30.5 (11.0:60.25)
Hand pain: Rest (mm VAS)
Right 29 (7.0:54.5) 19 (10.0:50.0) 22 (10.0:51.5)
Left 39 (10.0:50.0) 14 (5.5:25.5) 16.5 (6.25:42.5)
Medication: PainKillers (Number per day) 1.7 (1.2) 1.6 (1.0) 1.6 (1.1)
DAS28c 3.6 (1.1) 3.2 (1.1) 3.4 (1.1)
Tender joint count (28 joints) 5.8 (5.7) 4.1 (3.7) 5.0 (4.8)
Swollen joint count (28 joints) 1.5 (1.7) 1.3 (1.7) 1.4 (1.7)
CRPd 5.3 (6.6) 5.4 (9.8) 5.3 (8.1)
Disease activity (mm) (VAS) 47.19 (26.86) 41.19 (24.93) 44.19 (25.85)
ESRe 16.1 (11.3) 15.2 (12.7) 15.6 (11.9)
UltraSound (US)
US score: synovial hypertrophy (0-126) 16.5 (15.6) 20.4 (23.2) 18.5 (19.8)
Synovial perfusion (Doppler activity) (0-126) 5.6 (11.6) 6.7 (12.8) 6.2 (12.1)
US score: sum (0-252) 22.2 (25.9) 27.1 (35.2) 24.7 (30.9)
aAMPS Assessment of Motor and Process Skills
bHAQ-DI Stanford Health Assessment Questionnaire Disability Index
cDAS28 Disease Activity Score 28
dCRP C-reactive protein
eESR Erythrocyte Sedimentation Rate
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DAS28 was only minor and is not reaching the cutoff
for a clinically relevant change [40] and was not trans-
lated into improved ADL ability.
Despite statistically significant increases in observed
ADL ability, similar changes in self-reported ADL ability
were not seen across groups neither when using the
diagnosis specific instrument HAQ-Di, nor the generic
ADL-Q. These findings are in correspondence with the
results reported in a study by Amris et al. [17]. In that
study, a 2-week multi-component rehabilitation course
resulted in improvements in observed ADL ability in pa-
tients with chronic widespread pain, but these improve-
ments were not reflected in scores of self-reported
functional abilities on standardized questionnaires. Thus,
our study supports the notion that observation-based
evaluations of ADL ability may be more sensitive to
measure changes following intervention than self-report.
The hypothesis that participants receiving hand exer-
cise would have no increase in disease activity was con-
firmed. Thus, no negative effect on disease activity after
exercise was seen either assessed locally by US examin-
ation, by count of swollen and tender joints of the hand,
or globally as measured by inflammatory blood markers.
In contrast, a significant increase in ESR was seen in the
CIPCONTROL group; however, ESR is a very slow reacting
marker of disease activity and none of the other markers
of disease activity showed the same tendency.
In this randomized trial, the exercise program did not
reduce hand-related pain. In other studies, investigating
the effect of hand-exercise programs in RA, there are
Table 2 Changes from Baseline in Primary and Secondary Outcomes Analyses based on the Intention-To-Treat-Population
CIPEXERCISE (n=27)
Mean change
(95% CI)
CIPCONTROL (n=27 )
Mean change
(95% CI)
Group difference
Mean change (95%CI)
P-value
AMPSa ADL motor ability 0.24 (0.09 to 0.39) 0.20 (0.05 to 0.35) 0.04 (-0.16 to 0.25) 0.70
AMPSa ADL process ability 0.05 (-0.05 to 0.14) 0.02 (-0.07 to 0.12) 0.02 (-0.11 to 0.16) 0.73
ADL-Questionnaire (ADL-Q) 0.09 (-0.01 to 0.20) 0.09 (-0.02 to 0.19) 0.01 (-0.15 to 0.16) 0.90
HAQ-DIb -0.09 (-0.19 to 0.01) 0.01 (-0.09 to 0.11) -0.1 (-0.24 to 0.04) 0.16
Hand strength and pain
Max grip strength (Kg)
Right 1.43 (0.40 to 2.45) 0.18 (-0.86 to 1.23) 1.24 (-0.22 to 2.71) 0.10
Left 1.00 (-0.47 to 2.47) 0.36 (-0.71 to 3.44) 1.36 (-0.71 to 3.44) 0.20
Hand pain, Activity (mm VAS
Right -1.10 (-7.90 to 5.78) 0.57 (-6.27 to 7.41) -1.63 (-11.30 to 8.04) 0.74
Left -5.26 (-12.80 to 2.28) -0.78 (-8.31 to 6.76) -4.48 (-15.28 to 6.30) 0.41
Hand pain, Rest (mm VAS)
Right -1.43 (-8.63 to 5.78) 2.87 (-4.33 to 10.07) -4.30 (-14.49 to 5.00) 0.40
Left -1.67 (-9.71 to 6.36) 4.41-(-3.62 to 12.45) -6.08 (-17.80 to 5.62) 0.30
PainKillers (Number per day) 0.01 (-0.19 to 0.22) 0.01 (-0.22 to 0.19) 0.02 (-0.26 to 0.31) 0.87
DAS28c -0.17 (-0.49 to 0.15) 0.26 (-0.10 to 0.53) -0.39 (-0.84 to 0.07) 0.09
Tender joint count -0.51 (-1.83 to 0.82) 0.38 (-0.93 to 1.68) -0.88 (-2.75 to 0.99) 0.35
Swollen joint count 0.23 (-0.27 to 0.72) 0.15 (-0.33 to 0.63) 0.08 (-0.61 to 0.77) 0.82
CRPd -0.67 (-2.44-1.11) 1.76 (-0.12-3.63) -2.42 (-5.00-0.15) 0.06
Disease activity (VAS) -7.97 (-15.86—0.09) -0.70 (-7.93 to 6.53) -7.27 (-17.97 to 3.43) 0.18
ESRe -0.50 (-2.52 to 1.51) 2.30 (0.29 to 4.32) -2.80 (-5.65 to 0.05) 0.05
Ultra Sound (US)
US score: synovial hypertrophy 0.18 (-2.0 to 2.32) 1.83 (-0.22 to 3.89) -1.66 (-4.63 to 1.32) 0.27
Synovial perfusion (Doppler) -0.38 (-2.47 to 1.72) 1.01 (-0.99 to 3.03) -1.39 (-4.29 to 1.51) 0.34
UL score total -1.81 (-5.76 to 2.34) 2.56 (-1.23 to 6.36) -4.37 (-9.86 to 1.11) 0.12
aAMPS Assessment of Motor and Process Skills
bHAQ-DI Stanford Health Assessment Questionnaire Disability Index
cDAS28 Disease Activity Score 28
dCRP C-reactive protein
eESR Erythrocyte Sedimentation Rate
fAntiCCP anti Cyclic Citrullinated Peptides
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diverse findings regarding reduction in pain after exer-
cise; in two studies, reductions in pain measured on a
VAS scale was reported [5, 41], whereas two other
studies showed no pain reduction [6, 10]. The studies
reporting pain reduction did not evaluate functional
ability [5, 41]. The two studies reporting no pain
reduction evaluated and reported improvements in func-
tional ability (i.e., hand function, ADLs, pain, work
performance, esthetics, and patient satisfaction with
hand function) [8–10] and in evaluation of grip ability
[6]. These findings suggest that pain and functioning are
not necessarily closely linked factors, which is also seen
in a study investigating exercise therapy in patients with
impaired shoulder function [42]. Thus, the absence of
any significant effect of our hand-exercise intervention
on ability cannot be explained by unchanged pain in the
hand after exercise.
One limitation of the study was not reaching the
intended sample size. Still, the risk of overlooking a real
group difference in primary outcome is minor, as both
groups obtained a statistically significant increase in
ADL motor ability with no indication of a group differ-
ence. Another limitation is that the disease duration was
longer in the CIPCONTROL compared to that in the CIP-
XERCISE despite the randomized design. However, no pro-
nounced difference in any of the functional measures,
grip strength or disease activity score (DAS28) was seen
between the two groups strongly indicating the groups
were comparable.
Conclusion
In conclusion, participants in both CIPCONTROL and
CIPEXERCISE improved their ADL motor ability, but no sta-
tistically significant difference between groups was seen.
Moreover, no differences between groups were seen in
secondary outcomes. Thus, based on our results, it cannot
be concluded that hand exercise as an add on to compen-
satory intervention further improves observed ADL ability
in persons with RA-related impaired hand function.
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